Hospital Universitario De Cruces — Clinical Trial Site

189 Registered trials

95 Currently recruiting

Organisation

Hospital Universitario De Cruces

Location

Barakaldo, Spain

Identifier

ORG-100028621

Address

Cruces Plaza S/n, 48903, Spain

Departments

-
#5403 :neurologia
1306: Neurology
3104: neurologia
3401: Neurología
7002: Oncologia
7013: Oncología Médica
7222: Neurology
7513 Rheumatology
Anestesiología y Reanimación
anestesiology
Cardiology
Cardiothoracic anesthesiology department
Children's Nephrology Unit
cirugia
CIRUGIA VASCULAR Y ANGIOLOGIA
Clinical Haematology
Departamento de Neurología
DERMATOLOGIA
Dermatology
Endocrinología Pediátrica
Endocrinology
Enfermedades Infecciosas
ES10054: Hematologia
Gynecology and Obstetrics
Hematología
Hematologia y Oncologia Pediatricas
Hematology
Hematology and Hemodynamic Service
Hematology and Hemotherapy
Hematology Unit
Hepatobiliary Surgery and Liver Transplantation
Hepatobiliary surgery and liver transplantation unit
Hospital de Cruces( #16)
Hospital Universitario de Cruces
infecciosas
infectious diseases
Infectious Diseases Department
Infectious Diseases Unit
Inmunology
Internal Medicine
Medica Oncology
Medical Oncology
Medicina fisica y Rehabilitación
N/A
Nefrología
Nefrologia pediátrica
Neonatology
Nephrology
Neumología
Neumologia Pediatrica
Neurología
neurologia pediatrica
Neurology
Neurology Service
Obstetrician and Gynecologist
Oftalmologia
Oncología
Oncología Médica
Oncología Radioterápica
Oncology
Oncology for pediatrics
Oncology service
Ophtalmology
ORL
Paediatric Oncology Department
Paediatric Emergency Department
Pediatric
Pediatric Endocrinology
Pediatric Hemato-Oncology
Pediatric Hemato-Oncology Department
Pediatric hematology and oncology
Pediatric Nephrology
Pediatric Neurology
Pediatric Oncohematology
Pediatric Oncology
Pediatric Oncology and Haematology
Pediatric Oncology and Hematology
Pediatric oncology and hematology department
Pediatric Oncology and Hematology Section
Pediatric oncology department
Pediatric Oncology/Hematology
Pediatrics
Pediatrics Service. Pediatrics metabolism Section.
Pulmonology
Radiation Oncology
Radiotherapeutic Oncology
Radiotherapy oncology service
Reumatology
Rheumatology
Servicio de digestivo
Servicio de Enfermedades Infecciosas
Servicio de Oncología
Servicio de Oncología y Hematología Pediátricas
Servicio de Pediatría, Unidad de Enfermedades Raras Metabólicas
Servicio de Pediatría. Sección de Enfermedades Metabólicas Hereditarias
Servicio Hematologia
Servicio Neumologia
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad del Dolor
Unidad Oncohematología pediátrica.Hospital Universitario Cruces
Urology

Clinical trials at this site (189)

Search interface

A Study to evaluate Efficacy, Safety, Tolerability and Effects of TAK-341 in the human body in patients with Multiple System Atrophy Ended

2023-509876-40-00 Multiple System Atrophy 4 2022-11-22
Study to compare overall survival (OS) between subjects who receive SBP-101 and those who do not receive SBP-101 (i.e., placebo) in combinat… Ended

2024-514714-12-00 Metastatic Pancreatic Ductal Adenocarcinoma 10 2022-11-11
A Phase 2a, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington’s D… Ended

2023-509835-26-00 Huntington’s Disease 4 2022-07-06
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 Ended

2024-519691-10-00 Septic Shock 6 2022-05-27
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 Acute Ischemic Stroke 6 2022-05-01
A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents … Ended

2024-513304-33-00 Type 1 diabetes mellitus 5 2022-03-17
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
A continuation study to evaluate the prophylactic and on demand treatment of congenital Thrombotic Thrombocytopenic Purpura (cTTP) with the … Ended

2024-513839-24-00 Congenital Thrombotic thrombocytopenic purpura (cTTP) 5 2021-09-07
Study of efficacy and tolerability of ofatumumab vs. First Line disease modifying treatment (DMT) - physician’s choice in the treatment of n… Ended

2023-507431-37-00 relapsing multiple sclerosis (RMS) 5 2021-07-23
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16
HOPE study Ended

2024-516642-19-01 Acute Ischemic Stroke 6 2021-06-16
An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS transitioning from fumarate-based RMS approv… Ended

2023-507493-41-00 relapsing multiple sclerosis (RMS) 5 2020-08-04
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev… Ended

2022-502361-15-00 Moderate-to-Severe Plaque Psoriasis 5 2019-12-12
A Single-arm Study of Intrathecal SHP611 in Subjects with Metachromatic Leukodystrophy Ended

2024-514402-31-00 Late Metachromatic Leukodystrophy (MLD) 4 2019-09-09
A study comparing current standard therapies with fedratinib for the treatment of myelofibrosis (either diagnosed alone or after polycythemi… Ended

2024-511972-33-00 Primary myelofibrosis, post-polycythemia vera myelofibr 5 2019-08-05
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectable Ended

2024-513731-24-00 Non-small cell lung cancer (NSCLC) 4 2019-05-14
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Ended

2024-510751-34-00 Gaucher's disease type I; Gaucher's disease type III 5 2019-03-26
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
BEACON: A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma Ended

2024-518931-12-00 Neuroblastoma 4 2014-05-15
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5
Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial. Ended

2024-513188-17-03 Recurrent pancreatitis 6